Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Polycythemia Vera × Interferons × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 2 Polycythemia Vera 1 Lymphoma 1 Colonic Neoplasms 1

Interventions

ruxolitinib 4 Hydroxyurea 4 Phlebotomy 2 pomalidomide 1 liposomal amphotericin B 1 givinostat hydrochloride 1 givinostat 1 bomedemstat 1 anagrelide 1 Pipobroman 1 Pharmacogenomic Testing 1 Ondansetron 1 Morphine 1 Lenalidomide 1 Ketamine 1 Interferons 1 Interferon-alpha 1 Hypericum extract LI 160 1 Fentanyl 1 Early Intervention, Educational 1 Dextromethorphan 1 Aspirin 1 Asian ginseng 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116502 2024-11-18

MITHRIDATE

University of Birmingham

Phase 3 Recruiting

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡